SevenOneSeven Capital Management’s Idexx Laboratories IDXX Stock Holding History

SevenOneSeven Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-521	Closed	-$324K	–	55
2021 Q3	$324K	Buy	521 +6	+1%	+$4.03K	0.82%	35
2021 Q2	$325K	Buy	515 +8	+2%	+$4.42K	0.85%	32
2021 Q1	$248K	Buy	507 +37	+8%	+$18.5K	0.91%	36
2020 Q4	$235K	Buy	+470	New	+$210K	2.01%	20

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SevenOneSeven Capital Management's IDXX Position: Q4 2021 in Review

SevenOneSeven Capital Management sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 521 shares — an estimated $324K sold.

SevenOneSeven Capital Management first reported a position in IDXX in Q4 2020 and held it in 4 quarters. The position peaked at $325K in Q2 2021. 1,107 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

SevenOneSeven Capital Management reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
SevenOneSeven Capital Management sold 521 Idexx Laboratories shares in Q4 2021, an estimated $324K.
SevenOneSeven Capital Management first reported a position in Idexx Laboratories in Q4 2020 and held it in 4 quarters.
SevenOneSeven Capital Management's Idexx Laboratories position peaked at $325K in Q2 2021.
1,107 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on SevenOneSeven Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.